Variant report
Variant | esv3310726 |
---|---|
Chromosome Location | chr14:97389984-97390361 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:97388464..97390562-chr14:97391698..97394069,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74078706 | chr14:97389992-97389993 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74862616 | chr14:97390013-97390014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs534076780 | chr14:97390022-97390023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112350732 | chr14:97390047-97390048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181515645 | chr14:97390051-97390052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs374202055 | chr14:97390055-97390056 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368707938 | chr14:97390063-97390064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372887645 | chr14:97390079-97390080 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570746496 | chr14:97390088-97390089 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538065905 | chr14:97390098-97390099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs10138714 | chr14:97390117-97390118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556453599 | chr14:97390123-97390124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10149554 | chr14:97390127-97390128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs72478861 | chr14:97390156-97390157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11374628 | chr14:97390168-97390169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs397776060 | chr14:97390173-97390174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368364900 | chr14:97390184-97390185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs4905569 | chr14:97390188-97390189 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs575747385 | chr14:97390222-97390223 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542972761 | chr14:97390225-97390226 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572067468 | chr14:97390261-97390262 | Weak transcription Enhancers Genic enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9989241 | chr14:97390346-97390347 | Weak transcription Enhancers Genic enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
cataract | 16735990 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Developmental delay | 21147756 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 20164920 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 19435499 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 20139093 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Breast cancer | 21509527 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-small cell lung cancer | 18320023 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:97368600-97391400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr14:97379400-97411800 | Weak transcription | Primary T cells from cord blood | blood |
3 | chr14:97387000-97391400 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr14:97387200-97395200 | Weak transcription | Fetal Brain Male | brain |
5 | chr14:97388000-97391600 | Weak transcription | K562 | blood |
6 | chr14:97388400-97397400 | Weak transcription | Dnd41 | blood |
7 | chr14:97389400-97390200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr14:97389600-97391400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr14:97390200-97390400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr14:97390200-97390600 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr14:97390200-97391200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |